Summary
Allicense 2016 will bring together MVPs from the Pharma, Biotech and Financial communities to tackle today’s most relevant issues and shape the future of dealmaking in the BioPharma industry. This event brings together 200+ qualified dealmakers focus exclusively on key issues facing the industry. Chris Denn will speak on the panel Breakthrough Innovations.
Speakers
- /en/people/d/denn-christopher
Christopher J. Denn
Partner